MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$3.16 USD
+0.33 (11.66%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $3.18 +0.02 (0.63%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
MDxHealth SA (MDXH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.67 | $8.00 | $7.00 | 171.02% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for MDxHealth SA comes to $7.67. The forecasts range from a low of $7.00 to a high of $8.00. The average price target represents an increase of 171.02% from the last closing price of $2.83.
Analyst Price Targets (3 )
Broker Rating
MDxHealth SA currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MDXH.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/1/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
3/11/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
3/7/2024 | William Blair | Andrew F Brackmann | Not Available | Strong Buy |
3/7/2024 | Piper Sandler | Jason Bednar | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $7.67 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 58 of 253 |
Current Quarter EPS Est: | -0.26 |